So, which respiratory virus invaded your cells? Several types of viruses could be the culprit: respiratory syncytial virus ...

The RSVpreF vaccine demonstrated 91% effectiveness against RSV-related lower respiratory tract disease in older adults during ...

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

(HealthDay News) — Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by the American public, while confidence in other vaccines ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.

Newsweek has created a map showing states where respiratory syncytial virus (RSV) cases are surging.

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

Dr. April Miller with Mississippi Public Health Institute lists some RSV symptoms to look for. “The symptoms are typically ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...